Cargando…

The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon

BACKGROUND: Clinically, metastatic rectal cancer has been considered a subset of left-sided colon cancer. However, heterogeneity has been proposed to exist between high and middle/low rectal cancers. We aimed to examine the efficacy of anti-epidermal growth factor receptor (EGFR) treatment for middl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kun-Han, Chen, Wei-Shone, Jiang, Jeng-Kai, Yang, Shung-Haur, Wang, Huann-Sheng, Chang, Shih-Ching, Lan, Yuan-Tzu, Lin, Chun-Chi, Lin, Hung-Hsin, Huang, Sheng-Chieh, Cheng, Hou-Hsuan, Chao, Yee, Teng, Hao-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437976/ https://www.ncbi.nlm.nih.gov/pubmed/34188197 http://dx.doi.org/10.1038/s41416-021-01470-2

Ejemplares similares

A Long-Term and Large-Scale Real-World Study in Taiwan: Efficacy of Target Therapy in Stage IV Colorectal Cancer
por: Huang, Sheng-Chieh, et al.
Publicado: (2022)

Three-dimensional versus conventional two-dimensional laparoscopic colectomy for colon cancer: A 3-year follow-up study
por: Yang, Yi-Wen, et al.
Publicado: (2022)

Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients
por: Lu, Chieh-Sheng, et al.
Publicado: (2016)

The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study
por: Chang, Che-Yuan, et al.
Publicado: (2022)

Differences in gene mutations according to gender among patients with colorectal cancer
por: Tsai, Yi-Jian, et al.
Publicado: (2018)

Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spread
por: Hsu, Hung-Chih, et al.
Publicado: (2021)

Clinicopathological analysis of colorectal carcinoid tumors and patient outcomes
por: Lin, Hung-Hsin, et al.
Publicado: (2014)

Risk factors for delayed perineal wound healing and its impact on prolonged hospital stay after abdominoperineal resection
por: Chang, Chu-Cheng, et al.
Publicado: (2019)

Building personalized treatment plans for early-stage colorectal cancer patients
por: Lin, Hung-Hsin, et al.
Publicado: (2017)

Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery
por: Yang, Kai-Lin, et al.
Publicado: (2013)

Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report
por: Lin, Hung-Hsin, et al.
Publicado: (2016)

Clinicopathological and Molecular Features of Patients with Early and Late Recurrence after Curative Surgery for Colorectal Cancer
por: Lan, Yuan-Tzu, et al.
Publicado: (2021)

Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?
por: Tsai, Yi-Jian, et al.
Publicado: (2016)

A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer
por: Lin, Pei-Ching, et al.
Publicado: (2015)

Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma
por: Lan, Yuan-Tzu, et al.
Publicado: (2021)

Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences
por: Chang, Shih‐Ching, et al.
Publicado: (2019)

Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan
por: Lee, Yu-Ting, et al.
Publicado: (2015)

Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients
por: Kuan, Tai-Chuan, et al.
Publicado: (2018)

Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)
por: Chang, Shih-Ching, et al.
Publicado: (2020)

Molecular and Clinicopathological Differences by Age at the Diagnosis of Colorectal Cancer
por: Chang, Chu-Cheng, et al.
Publicado: (2017)

ER stress‐related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer
por: Liu, Chun‐Yu, et al.
Publicado: (2018)

The Prognostic Role of Para-Aortic Lymph Nodes in Patients with Colorectal Cancer: Is It Regional or Distant Disease?
por: Lu, Hsueh-Ju, et al.
Publicado: (2015)

Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer
por: Liu, Chun-Yu, et al.
Publicado: (2021)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer
por: Chen, Hung-Ming, et al.
Publicado: (2021)

Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway
por: Tsai, Hong-Chieh, et al.
Publicado: (2021)

Author Correction: Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway
por: Tsai, Hong-Chieh, et al.
Publicado: (2021)

Clinical relevance of cell-free DNA in gastrointestinal tract malignancy
por: Lan, Yuan-Tzu, et al.
Publicado: (2016)

Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy
por: Chen, Kuen-Feng, et al.
Publicado: (2015)

Taiwan Society of Colon and Rectum Surgeons (TSCRS) Consensus for Anti-Inflammatory Nutritional Intervention in Colorectal Cancer
por: Ma, Cheng-Jen, et al.
Publicado: (2022)

Synchronous triple carcinoma of the colon and rectum
por: Yeh, Chien-Chih, et al.
Publicado: (2013)

Serum CA125 concentration as a predictor of peritoneal dissemination of colorectal cancer in men and women
por: Huang, Chi-Jung, et al.
Publicado: (2016)

Characteristics of primary signet ring cell carcinoma of colon and rectum: a case control study
por: Weng, Meng-Tzu, et al.
Publicado: (2022)

Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer()()
por: Fan, Li-Ching, et al.
Publicado: (2015)

Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer
por: Fan, Li-Ching, et al.
Publicado: (2016)

Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced EGFR-Mutant Lung Adenocarcinoma
por: Lee, Po-Hsin, et al.
Publicado: (2022)

The Colon, Rectum and Anus
Publicado: (1933)

Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer
por: Liao, Tsai-Tsen, et al.
Publicado: (2020)

Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study
por: Lin, Tzu-Min, et al.
Publicado: (2018)

Comparison of risk factors between colon cancer and rectum cancer in a single medical center hospital, Taiwan
por: Lee, Chao-Hsien, et al.
Publicado: (2019)

SURGERY OF THE ANUS, RECTUM AND COLON
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_aeih3njttq11v9nfdclt6va8q2